Mobile

An Exploratory Study to Evaluate the Kinetics of Viral Load Decline with Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Therapy with Low Dose Ribavirin (RBV), Full Dose RBV or RBV A...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-001478-32

An Exploratory Study to Evaluate the Kinetics of Viral Load Decline with Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Therapy with Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment-Naïve Adults with Genotype 1a Chronic Hepatitis C Virus (HCV) Infection

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

HCV RNA early viral load decline in the plasma following combination of ombitasvir/ABT-450/r and dasabuvir administered with low dose, full dose, or no RBV in treatment-naive HCV genotype GT 1a-infected adults

Critère d'inclusion

  • Chronic Hepatitis C Virus (HCV) Infection

Liens